Evidence-Based Medicine Guidelines
Oral contraceptives and the risk of ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Contraceptives and the Risk of Ovarian Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451466/all/Oral_contraceptives_and_the_risk_of_ovarian_cancer.
Oral contraceptives and the risk of ovarian cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/451466/all/Oral_contraceptives_and_the_risk_of_ovarian_cancer. Accessed November 23, 2024.
Oral contraceptives and the risk of ovarian cancer. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451466/all/Oral_contraceptives_and_the_risk_of_ovarian_cancer
Oral Contraceptives and the Risk of Ovarian Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451466/all/Oral_contraceptives_and_the_risk_of_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral contraceptives and the risk of ovarian cancer
ID - 451466
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451466/all/Oral_contraceptives_and_the_risk_of_ovarian_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
